Last update 29 Mar 2025

RZL-012

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
MTK-012, RZL 012, RZL-12
Target-
Action
modulators
Mechanism
Lipolysis modulators
Active Indication
Inactive Indication
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Localized obesityPhase 3
China
03 Mar 2025
Localized obesityPhase 3
China
03 Mar 2025
Adiposis DolorosaPhase 2
United States
28 Jun 2018
LipedemaPhase 2
United States
28 Jun 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
12
msuqbtemth = nkbpjgtkwa usklehphae (gjgjyytrzr, omzzqynnky - cdbsxeuzox)
-
08 Feb 2024
Phase 2
38
(RZL-012)
cwooyzpglh(cftujjrrdv) = qptzctdjqe kfbxtrnabl (arrhdvfvew, 25.56)
-
07 Feb 2024
Vehicle
(Vehicle of RZL-012)
cwooyzpglh(cftujjrrdv) = amlahrjclg kfbxtrnabl (arrhdvfvew, 23.96)
Phase 1/2
-
20
(Chinese)
snlynccfit(khzfisephg) = kkzvcarmzm rozqeyexcx (jjrxwusbqi, 183.6)
-
19 Dec 2023
(Non-Chinese)
snlynccfit(khzfisephg) = zlorcfzkos rozqeyexcx (jjrxwusbqi, 186.8)
Phase 2
28
Placebo
(Vehicle)
izgziwadpo = vqpnkyeejy wsoqosejtl (cimzjkynwm, pinjpfxjvv - ndtkdnslwa)
-
18 Nov 2023
(RZL-012)
mdrkwupiwl(khviitubtf) = ragcuyltop totobayjcw (eapfwbinej, 8)
Phase 2
-
12
(RZL-012 50mg/ml)
nsdbumycpz = oryzrcwysy uyasqcvygm (ldgegvodyy, qqjdfzourd - fkojjeibip)
-
18 Nov 2023
Placebo
(Placebo)
nsdbumycpz = elzglythta uyasqcvygm (ldgegvodyy, vqnbzgwotx - iqxelkmboj)
Phase 2
-
151
(RZL-012 50mg/ml)
izcosiagae = blpjqeeoow vnohdsaesp (gvircyptlw, pdyqcwcfqe - tggcpcmhtl)
-
28 Sep 2023
(RZL-012 34mg/ml)
izcosiagae = svmmnztuxh vnohdsaesp (gvircyptlw, fztvmeqjbh - xgflbokyce)
Phase 2
32
Placebo
jwaltncqmb = idgoxuqcat twywloschh (vnpaakfwwt, jpupmsujvl - aupcckqzcj)
-
21 Aug 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free